Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...
Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below ...
Stocks Trim Losses On Mexico Tariff Delay, Gold Extends Records, Tesla Sinks 6%: What's Driving Markets Monday? Wall Street bounced back after President Donald Trump and Mexican President Claudia ...
In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops ...
IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...
Early data shows IDEXX Cancer Dx testing can detect lymphoma before clinical signs are present, 5 supporting its utility in routine preventive care for at-risk dogs. "Building on over 40 years of ...
Company Information Key Financials (last Fiscal Year) Profit Ratios Earnings Per Share (last Fiscal Year) Total Return © 2025 Fortune Media IP Limited. All Rights ...
Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of $510.00. The company’s shares closed last Friday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback